Preventing mother-to-child transmission of HIV-1

Paediatrics and Child Health

Volumn 17, Issue 4, 2007, Pages 126-131

  Foster, CJ ^a   Lyall, EGH ^a  

^a NONE

Author keywords

antiretroviral therapy; HIV; mother to child transmission; perinatal

Indexed keywords

ABACAVIR; AZATHIOPRINE; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PLACEBO; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; BREAST FEEDING; CESAREAN SECTION; CLINICAL TRIAL; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY REACTION; LABOR; LYMPHOCYTE COUNT; MONOTHERAPY; NEUTROPENIA; PLACENTAL TRANSFER; PREGNANCY; RASH; RISK ASSESSMENT; SINGLE DRUG DOSE; UNITED KINGDOM; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 34247166580     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.01.017     Document Type: Article

References (23)

1. Joint United Nations Programme on HIV/AIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS; 2006. Available at 〈www.unaids.org〉
2. Health Protection Agency. Mapping the issues. HIV and sexually transmitted infections in the UK, 2005. 〈www.hpa.org.uk〉
3. Struik S, Tudor-Williams G, Taylor GP, et al. Four cases of infant HIV due to seroconversion in pregnancy: should partner screening and/or repeat 3rd trimester HIV screening be recommended in the UK? XIIth Annual Meeting of the British HIV Association, Brighton, April 2006 [P. 68].
4. International Perinatal HIV Group. Mode of delivery and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies. N Engl J Med 340 (1999) 977-987
5. European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 353 (1999) 1035-1039
6. International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies. AIDS 15 (2001) 357-368
7. Ioannidis J.P., Abrams E.J., Ammann A.J., et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis 183 (2001) 539-545
8. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40 (2005) 458-465
9. Garcia P.M., Kalish L.A., Pitt J., et al. Viral load and risk of transmission. N Engl J Med 341 (1999) 394-402
10. Connor E.M., Sperling R.S., Gelber R., et al. Paediatric AIDS Clinical Trial Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331 (1994) 1173-1180
11. Guay L.A., Musoke P., Fleming T., et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for the prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354 (1999) 795-802
12. Eshleman S.H., Hoover D.R., Chen S., et al. Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns. AIDS 19 (2005) 2167-2169
13. Jourdian G., Ngo-Giang-Huong N., Le Coeur S., et al. Perinatal HIV Prevention Trial Group. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 351 (2004) 229-240
14. Moodley D., Moodley J., Coovadia H., et al. South African Intrapartum Nevirapine Trial (SAINT) Investigators. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 187 (2003) 725-735
15. British HIV Association. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission, 2005 〈www.bhiva.org.uk〉
16. Suy A, Coll O, Martinez E, et al. Increased risk of pre-eclampsia and foetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. XV International AIDS Conference, Bangkok, 2004 [Abs ThOrB1359].
17. European Collaborative Study, Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 14 (2000) 2913-2920
18. National Surveillance of HIV in Pregnancy and Childhood Toronto abstract 2006.
19. Tuomala R.E., Shapiro D.E., Mofenson L.M., et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 346 (2002) 1863-1870
20. Blanche S., Tardieu M., Rustin P., et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354 (1999) 1084-1089
21. Divi R.L., Walker V.E., Wade N.A., et al. Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS 18 (2004) 1013-1021
22. Le Chenadec J., Mayaux M.J., Guihenneuc-Jouyaux C., and Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 17 (2003) 2053-2061
23. Townsend C.L., Tookey P.A., Cortina-Borja M., and Peckham C.S. Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003. J Acquir Immune Defic Syndr 42 (2006) 91-94